The US FDA has approved the HeartWare Ventricular Assist ... device (LVAD), which helps the heart’s left ventricle to pump oxygen-rich blood to the body. The mechanical pump is designed for ...
The delayed action raises questions for some safety advocates about how and when issues with approved ... blood from the pump to the aorta could twist and stop blood flow. The FDA recall notice ...
Opinions expressed by Forbes Contributors are their own. Dr. Omer Awan is a practicing physician who covers public health. CARLSBAD, CA-NOV 30TH: Mounjaro injection pen on display at Rachel Graham ...
The latest development in health is that the US Food and Drug Administration (FDA) on August 26 approved the expanded use of ...
The U.S. Food and Drug Administration approved the drug on Thursday, greenlighting the first of a new class of treatments that could help stabilize patients’ symptoms without the uncomfortable ...
The FDA has approved the first two drugs for the rare genetic metabolic disorder Niemann–Pick disease, type C (NPC). Zevra Therapeutics’ arimoclomol (Miplyffa) is a once-rejected small ...
Medtronic has been notifying users of its MiniMed insulin pumps to be aware of potentially shortened battery lives and to heed the devices’ low-power warnings and alerts. Now, the FDA has ...
People with schizophrenia will have a new treatment option for the first time in more than three decades, after the Food and Drug Administration Thursday approved a new kind of drug. Studies ...
The FDA has approved a new injectable form of the multiple sclerosis drug ocrelizumab for use in adults with relapsing and progressive forms of the disease. Multiple sclerosis occurs when the body ...
People could previously get the nasal spray flu vaccine, called FluMist, from a health care provider, but now they can administer it themselves. A nasal spray version of the annual flu vaccine can ...
director of the FDA's Center for Biologics Evaluation and Research. The vaccine, which was first approved in 2003 to be administered only by healthcare providers, contains a weakened form of live ...
The FDA has approved Karuna/Bristol Myers Squibb’s KarXT (Cobenfy) — an oral dual M1/M4 muscarinic acetylcholine receptor (mAChR) agonist — for schizophrenia. The fixed-dose combination of ...